DE RIZ, MILENA ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 4.538
NA - Nord America 2.768
AS - Asia 1.330
SA - Sud America 125
OC - Oceania 34
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.814
Nazione #
US - Stati Uniti d'America 2.592
GB - Regno Unito 1.482
IT - Italia 879
DE - Germania 639
CN - Cina 622
SE - Svezia 478
IN - India 189
FR - Francia 158
CA - Canada 150
UA - Ucraina 150
TR - Turchia 139
IE - Irlanda 118
ES - Italia 117
KR - Corea 100
PL - Polonia 84
FI - Finlandia 69
BR - Brasile 65
RU - Federazione Russa 64
DK - Danimarca 62
IR - Iran 59
NL - Olanda 58
EU - Europa 57
JP - Giappone 45
HK - Hong Kong 44
CO - Colombia 41
BE - Belgio 39
GR - Grecia 36
VN - Vietnam 36
AU - Australia 31
SG - Singapore 31
CH - Svizzera 29
RO - Romania 23
MX - Messico 21
ID - Indonesia 20
IL - Israele 15
PT - Portogallo 12
CZ - Repubblica Ceca 10
MA - Marocco 7
NO - Norvegia 7
VE - Venezuela 7
CL - Cile 6
JO - Giordania 6
AT - Austria 5
EG - Egitto 5
TW - Taiwan 5
CU - Cuba 4
QA - Qatar 4
DZ - Algeria 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
UZ - Uzbekistan 3
AR - Argentina 2
CY - Cipro 2
KW - Kuwait 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
MK - Macedonia 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
EC - Ecuador 1
HR - Croazia 1
HU - Ungheria 1
LV - Lettonia 1
MT - Malta 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 8.870
Città #
Southend 1.288
Chandler 333
Milan 208
Wilmington 147
Princeton 144
Seattle 134
Beijing 128
Dublin 110
Ann Arbor 109
Frankfurt am Main 107
Ashburn 106
Jacksonville 99
Redwood City 94
Berlin 77
Nanjing 76
Toronto 76
Woodbridge 74
Fairfield 70
New York 62
Houston 57
Redmond 56
Warsaw 55
Mountain View 53
Bengaluru 51
Ottawa 50
Des Moines 46
Dearborn 45
Kent 45
Somerville 44
Jinan 43
Rome 40
Sakarya 37
Cambridge 36
Andover 35
Bogotá 35
Phoenix 35
Shanghai 35
Shenyang 34
Boardman 33
Serra 30
Hong Kong 27
Margão 26
Nanchang 26
Madrid 25
Athens 24
Hangzhou 22
Tianjin 21
Brussels 20
Norwalk 20
Duncan 19
Helsinki 19
Dong Ket 18
Fremont 15
Jiaxing 15
Barcelona 14
London 14
Nürnberg 14
Bari 13
Brescia 13
Chicago 13
Kiez 13
Paris 13
Turin 13
Zhengzhou 13
Changsha 12
São Paulo 12
Fuzhou 11
Hebei 11
Ningbo 11
Padova 11
Central District 10
Medford 10
Auburn Hills 9
Birmingham 9
Dallas 9
Eitensheim 9
Istanbul 9
Lanzhou 9
Manipal 9
Muggiò 9
Tokyo 9
Arosio 8
Bühl 8
Chengdu 8
Genova 8
Guangzhou 8
Naples 8
Prague 8
Seoul 8
Tehran 8
Adelaide 7
Cagliari 7
Greenford 7
Iowa City 7
Liège 7
Mexico City 7
Napoli 7
Palermo 7
San Diego 7
Siena 7
Totale 5.078
Nome #
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis 951
FATTORI DI RISCHIO GENETICI NELLA MALATTIA DI ALZHEIMER E NELLA DEMENZA FRONTOTEMPORALE: STUDIO DI ASSOCIAZIONE DI GENI CANDIDATI POSIZIONALI E FUNZIONALI 518
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis? 355
CSF β-amyloid predicts prognosis in patients with multiple sclerosis 340
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression 339
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 196
Changes in vitamin B12 and tumour necrosis factor-a levels in cerebrospinal fluid of patients with different subtypes of multiple sclerosis 163
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease 152
Loss of cobalamin-mediated regulation leads to decreased EGF and increased soluble CD40 levels in cerebrospinal fluid of patients with multiple sclerosis 149
Progranulin gene mutation scanning in multiple sclerosis patients with cognitive impairment 149
Progranulin genetic variability in primary progressive multiple sclerosis. 143
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. 138
Progranulin gene mutation scanning in Multiple Sclerosis patiens with cognitive impairment. 138
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 134
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 134
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 132
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 132
SELP and SELPLG single nucleotide polymorphisms in multiple sclerosis 130
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis 130
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 129
Reversible Parkinson's Dementia associated with withdrawal of androgen-deprivation therapy for prostate cancer 128
GRN rs5848 in neurodegeneration: a role in axonal damage? 127
A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation 127
Progranulin gene variability in a population of 239 patients with primary progressive multiple sclerosis 124
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 124
The effects of transcranial direct current stimulation (tDCS) on fatigue in Multiple Sclerosis 122
Gender-specific influence of the chromosome 16 gene cluster on the susceptibility to multiple sclerosis 119
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males 118
CXCL10 haplotypes and multiple sclerosis : association and correlation with clinical course 117
SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis 117
MDC/CCL22 intrathecal levels in patients with multiple sclerosis 116
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis : a longitudinal OCT study 116
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 114
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes 113
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 112
Role of hnRNP-A1 and miR-590-3p in neuronal death : genetics and expression analysis in patients with Alzheimer’s disease and frontotemporal lobar degeneration 111
C9ORF72 repeat expansion not detected in patients with multiple sclerosis 111
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 109
Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. 109
Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells 108
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 108
Expression profile of miRNAs involved in CD4+ lymphocyte activation and differentiation in patients with multiple sclerosis 106
Gender-specific influence of the chromosome 16 chemokine genecluster on the susceptibility to Multiple Sclerosis 105
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 105
GSK3β genetic variability in patients with Multiple Sclerosis 103
GRN rs5848 polymorphism: a role in neurodegeneration? 102
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 102
Xerophthalmia, xerostomia and primary Sjögren’s syndrome in multiple sclerosis patients treated with immunomodulating drugs : an Italian multicentre study 97
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 97
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers 96
Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis 95
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy 92
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation 92
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis 92
Expression and genetic analysis of miRNAs involved in CD4+cell activation in patients with multiple sclerosis 88
Role of hnRNP-A1 and miR-590-3p in Neuronal Death : Genetics and Expression Analysis in Patients with Alzheimer Disease and Frontotemporal Lobar Degeneration 87
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 86
Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis 85
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian M sclerosis and related disorders register 76
Expression and genetic analysis of microRNAs involved in multiple sclerosis 76
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease 76
Multiple sclerosis : BAFF and CXCL13 in cerebrospinal fluid 67
Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod 67
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis [Low CSF beta-amyloid levels predict early regional grey matter atrophy in multiple sclerosis] 43
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis : the Italian experience 40
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome 37
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study 35
miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis 34
Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis 21
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 16
null 3
Totale 9.323
Categoria #
all - tutte 21.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 0 71 53
2019/20201.137 118 74 58 61 51 89 97 65 207 189 78 50
2020/20211.495 126 160 107 65 127 101 78 96 144 96 211 184
2021/20221.075 84 83 42 54 84 72 86 62 148 103 75 182
2022/20231.414 172 188 121 155 119 227 57 87 147 36 69 36
2023/2024896 37 79 52 83 296 62 64 76 55 90 2 0
Totale 9.323